SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Genprex Identifies TROP2 as Potential Biomarker for Reqorsa Response

Genprex identified TROP2 as a potential biomarker for response to Reqorsa in lung cancer.

GNPX
SquawkNews Desk

Related stories

Burjeel Holdings Q3’26 Finance Costs Rise 66.5% to AED 62 Million M impact | EQUITY | Nov 04, 2026, 01:23 PM UTC Norwegian Air shares rise 5.2%, on track for best day since June M impact | EQUITY | Nov 04, 2026, 01:22 PM UTC Shringar House of Mangalsutra Reports Q2 Revenue of INR 8,186.6 Million M impact | EQUITY | Nov 04, 2026, 01:22 PM UTC Crédit Mutuel Arkéa Contains Cyberattack; Operations Gradually Resume The bank said clients’ assets were not affected. M impact | EQUITY | Nov 04, 2026, 01:22 PM UTC Crédit Mutuel Arkéa Contains Cyberattack as Operations Gradually Resume The bank said clients’ assets have not been affected. M impact | EQUITY | Nov 04, 2026, 01:22 PM UTC Crédit Mutuel Arkéa Says It Was Targeted in Cyberattack M impact | EQUITY | Nov 04, 2026, 01:22 PM UTC